CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)
Clinical trial NCT04627675 · TERMINATED
Trial details
- NCT number
- NCT04627675
- Sponsor
- Providence Health & Services
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2022-09-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.